The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves’ disease in a Mexican population-Reference-Cited by-同舟云学术

The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves’ disease in a Mexican population

Published:2017-05-12 Issue:9 Volume:66 Page:775-781
ISSN:1023-3830
Container-title:Inflammation Research
language:en
Short-container-title:Inflamm. Res.

Author:

López-Cano Daniela Josabeth,Cadena-Sandoval Daniel,Beltrán-Ramírez Olga,Barbosa-Cobos Rosa Elda,Sánchez-Muñoz Fausto,Amezcua-Guerra Luis Manuel,Juárez-Vicuña Yaneli,Aguilera-Cartas María Concepción,Moreno José,Bautista-Olvera Jesús,Valencia-Pacheco Guillermo,López-Villanueva Ricardo F.,Ramírez-Bello Julian^ORCID

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Immunology

Link

http://link.springer.com/article/10.1007/s00011-017-1056-0/fulltext.html

Reference42 articles.

1. Rincón JF, Cano DL, Morales SJ, Jiménez ML, Cobos RE, Bello JR. The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico. Clin Rheumatol. 2016;35:1457–62.

2. Stanford SM, Bottini N. PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol. 2014;10:602–11.

3. Fousteri G, Liossis SN, Battaglia M. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol. 2013;149:556–65.